Middle East & Africa Gastric Cancer Diagnostic Procedure Market Forecast to 2028 - Regional Analysis - by Healthcare Providers (Diagnostic Laboratories, Hospitals, Cancer Research Institutes, Oncology Specialty Clinics, and Others), Symptom Types (Symptom

Middle East & Africa Gastric Cancer Diagnostic Procedure Market Forecast to 2028- Regional Analysis- by Healthcare Providers (Diagnostic Laboratories, Hospitals, Cancer Research Institutes, Oncology Specialty Clinics, and Others), Symptom Types (Symptomatic and Asymptomatic), Body Fluid (Blood, Urine, Saliva, Stomach Wash/Gastric Juice, Tissue, and Others), Procedures (Endoscopic Procedures, Biopsy & Tissue Tests, Lab Tests, In-Vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics & Immunoassays, and Others), Offerings [Instruments, Reagents & Consumables (Including Kits), and Services], Disease Indication (Early Gastric Cancer and Advanced Gastric Cancer Types) and country

The Middle East & Africa gastric cancer diagnostic procedure market was valued at US$ 39.63 million in 2022 to US$ 51.05 million by 2028. It is estimated to grow at a CAGR of 4.3 % from 2022 to 2028.

Rising Awareness of Gastric Cancer Boosts Middle East & Africa Gastric Cancer Diagnostic Procedure Market

Hope For Stomach Cancer is another nonprofit organization that offers resources to patients, caregivers, and loved ones while promoting early detection and prevention in different communities (including medical and nonmedical). The organization develops and rolls out programs to assist stomach cancer patients to live the best possible life throughout the phases of the disease. Therefore, a rising number of gastric cancer awareness programs are expected to offer lucrative opportunities for the Middle East & Africa gastric cancer diagnostic procedures market during the forecast period.

Middle East & Africa Gastric Cancer Diagnostic Procedure Market Overview

The Middle East & Africa gastric cancer diagnostic procedure market is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Countries in this region report varied incidences of gastric cancer. According to the latest WHO data published in 2020, deaths caused due to stomach cancer reached 389 or 0.29% of total deaths in Saudi Arabia. Moreover, Dyspepsia, a type of gastrointestinal disease, is common across the country. Saudi Arabia records the highest prevalence of dyspepsia in the Gulf, which can potentially lead to more GI complications, poor health, and deteriorating national outcomes. According to an article published in 2019 by Saudi Journal of Gastroenterology, the prevalence rate of H. pylori in Saudi Arabia was reported to be in the range of 50–80% among symptomatic patients with dyspepsia and abdominal pain or in patients undergoing endoscopic procedures. According to an article published in 2021, the prevalence of H. pylori in Saudi Arabia was 71.33% in patients suffering from different biopsy-proven GI conditions, such as gastritis, peptic ulcer disease, and gastric cancer. An upsurge in the number of gastric/stomach cancer, ulcer disease, and GI condition cases favors the overall growth of the gastric cancer diagnostic procedure market.

Exhibit: Middle East & Africa Gastric Cancer Diagnostic Procedure Market Revenue And Forecast To 2028 (US$ Million)

Middle East & Africa Gastric Cancer Diagnostic Procedure Market Segmentation

The Middle East & Africa gastric cancer diagnostic procedure market is segmented into healthcare providers, symptom types, body fluid, procedures, offerings, disease indication, and country.

Based on healthcare providers, the Middle East & Africa gastric cancer diagnostic procedure market is segmented into diagnostic laboratories, hospitals, cancer research institutes, oncology specialty clinics, and others. The Hospitals segment held the largest gastric cancer diagnostic procedure market share in 2022.

Based on symptoms type, the South & Central America gastric cancer diagnostic procedure market is segmented into symptomatic and asymptomatic. The Asymptomatic segment held largest Middle East & Africa gastric cancer diagnostic procedure market share in 2022.

Based on body fluid, The Middle East & Africa gastric cancer diagnostic procedure market is segmented into Blood, urine, saliva, stomach wash/gastric juice, tissue and others. Blood segment held largest Middle East & Africa gastric cancer diagnostic procedure market share in 2022.

Based on offering, the Middle East & Africa gastric cancer diagnostic procedure market is segmented into Instruments, Reagents & Consumables and Services. Reagents & Consumables segment held the Middle East & Africa gastric cancer diagnostic procedure market share in 2022.

Based on Diagnostic procedure, the Middle East & Africa gastric cancer diagnostic procedure market is categorized into Endoscopic procedure, Biopsy and tissue tests, lab test, In-vitro diagnostic tests, Imaging Test, Molecular Diagnostics, Multiplexing molecular Diagnostics, Immunoassay, and others. The imaging segment held largest Middle East & Africa gastric cancer diagnostic procedure market share in 2022.

Based on disease condition, the Middle East & Africa gastric cancer diagnostic procedure market is segmented into Early Gastric cancer and Gastric cancer advanced types. The Gastric cancer advanced type segment held larger Middle East & Africa gastric cancer diagnostic procedure market share in 2022.

Based on country, the Middle East & Africa gastric cancer diagnostic procedure market has been segmented into Saudi Arabia, South Africa, the UAE, and Rest of the Middle East & Africa. Saudi Arabia dominated the market in this region in 2022.

Bio-Rad Laboratories Inc; F. Hoffmann-La Roche Ltd; bioMerieux SA; Thermo Fisher Scientific Inc; Illumina Inc; and Vela Diagnostics Holding Pte Ltd. are the leading companies operating in the Middle East & Africa gastric cancer diagnostic procedure market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa gastric cancer diagnostic procedure market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in Middle East & Africa gastric cancer diagnostic procedure market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Middle East & Africa gastric cancer diagnostic procedure market trends and outlook coupled with the factors driving the Middle East & Africa gastric cancer diagnostic procedure Market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution